Works about SUBSTANCE P receptors


Results: 390
    1
    2
    3
    4
    5

    Comparison between Substance P and Calcitonin Gene-Related Peptide and Their Receptors in Colorectal Adenocarcinoma.

    Published in:
    Journal of Clinical Medicine, 2024, v. 13, n. 18, p. 5616, doi. 10.3390/jcm13185616
    By:
    • Șerban, Robert-Emmanuel;
    • Boldeanu, Mihail Virgil;
    • Florescu, Dan Nicolae;
    • Ionescu, Mihaela;
    • Șerbănescu, Mircea-Sebastian;
    • Boldeanu, Lidia;
    • Florescu, Mirela-Marinela;
    • Stepan, Mioara-Desdemona;
    • Obleagă, Vasile-Cosmin;
    • Constantin, Cristian;
    • Popescu, Dragoş-Marian;
    • Streba, Costin Teodor;
    • Vere, Cristin Constantin
    Publication type:
    Article
    6
    7
    8

    Substance P—Friend or Foe.

    Published in:
    Journal of Clinical Medicine, 2022, v. 11, n. 13, p. 3609, doi. 10.3390/jcm11133609
    By:
    • Robinson, Prema;
    • Rodriguez, Emma;
    • Muñoz, Miguel
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21

    Alitretinoin for prurigo nodularis.

    Published in:
    Clinical & Experimental Dermatology, 2021, v. 46, n. 2, p. 362, doi. 10.1111/ced.14385
    By:
    • Maqbool, T.;
    • Kraft, J. N.
    Publication type:
    Article
    22
    23
    24
    25
    26
    27
    28
    29

    Evaluation of antipruritic effects of serlopitant, a neurokinin 1 receptor antagonist, in patients with epidermolysis bullosa: A phase 2 randomized controlled trial.

    Published in:
    Journal of the European Academy of Dermatology & Venereology, 2025, v. 39, n. 3, p. e215, doi. 10.1111/jdv.20189
    By:
    • Okata‐Karigane, Utako;
    • Pathmarajah, Pirunthan;
    • Gorell, Emily S.;
    • Sum, Katie;
    • Yekrang, Kiana;
    • Phung, Michelle;
    • Barriga, Melissa;
    • Udrizar, Patricia;
    • Bailey, Irene;
    • Li, Shufeng;
    • Lu, Ying;
    • Tang, Jean Y.;
    • Chiou, Albert S.
    Publication type:
    Article
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47

    Efficacy and safety of aprepitant for the prevention of chemotherapy-induced nausea and vomiting during the first cycle of moderately emetogenic chemotherapy in Korean patients with a broad range of tumor types.

    Published in:
    2017
    By:
    • Kim, Jeong;
    • Jang, Joung-Soon;
    • Kim, Jae-Weon;
    • Sung, Yong;
    • Cho, Chi-Heum;
    • Lee, Myung-Ah;
    • Kim, Do-Jin;
    • Ahn, Myung-Ju;
    • Lee, Kil;
    • Sym, Sun;
    • Lim, Myong;
    • Jung, Hun;
    • Cho, Eun;
    • Min, Kyung;
    • Kim, Jeong Eun;
    • Sung, Yong Lee;
    • Lee, Kil Yeon;
    • Sym, Sun Jin;
    • Lim, Myong Choel;
    • Cho, Eun Kim
    Publication type:
    journal article
    48
    49